A r t i c l e s
The mucosal surface of the mammalian gut is continuously exposed to a variety of foreign proteins and microorganisms, some of which are potentially harmful to the host. To protect the host from these dangers, the intestinal mucosa has evolved specialized organized lymphoid tissues. Gut-associated lymphoid tissue (GALT), including Peyer's patches (PPs) and isolated lymphoid follicles, is the inductive site for intestinal immunity. Different from other peripheral lymphoid tissues, GALT lacks afferent lymphatics and directly samples mucosal antigens across the epithelial barrier to initiate immune responses. This task is accomplished by specialized epithelial cells, known as 'microfold cells' (M cells), in the follicle-associated epithelium (FAE) covering the lymphoid follicles of GALT. M cells have a large capacity for phagocytosis and transcytosis; these functions allow the rapid transport of antigens to underlying lymphoid tissues, especially antigen-presenting cells. Antigens are then presented to T cells that support B cell activation, which ultimately results in the generation of plasma cells that produce immunoglobulin A. Thus, M cell-mediated transport of antigen is an important step in the initiation of mucosal immune responses [1] [2] [3] .
M cells have characteristic morphological features that set them apart from other subsets of intestinal epithelial cells. They have shorter and irregular microvilli on their apical surface and a pocket-like basolateral invagination of the plasma membrane that houses lymphocytes and antigen-presenting cells 3 . These morphological features enable the recognition of M cells by transmission or scanning electron microscopy. Although the functional and morphological features of M cells were initially described nearly 40 years ago 4, 5 , many basic questions about M-cell differentiation and function remain unsolved. Gene-expression profiling of M cells has been used as one approach to learn more about M cells, and several M cell-specific molecules have been identified, including GP2, Marcksl1, M-Sec, Sgne-1, annexin V and CCL9 (refs. 6-11) . Among those, GP2 mediates the uptake of bacteria that express FimH, a component of type I pili on the bacterial outer membrane, to initiate subsequent bacteria-specific immune responses 6 .
M cells are a small subset of intestinal epithelial cells derived from intestinal epithelial stem cells 12, 13 . Because of the restricted localization of M cells in the FAE, it has been postulated that the cells of the immune system in GALT are involved in M-cell differentiation. Among those, the contribution of B cells to M-cell differentiation has been demonstrated in vivo and in vitro [14] [15] [16] . In addition to the contribution of hematopoietic cells, mesenchymal cells in the subepithelial dome of PPs have an essential role in M-cell differentiation by producing RANKL, a cytokine of the tumor necrosis factor superfamily 17 . Indeed, RANKL-deficient mice have considerably fewer M cells, and exogenous administration of recombinant RANKL restores the number of M cells in these mice. Furthermore, treatment with RANKL can induce ectopic differentiation of cells of the villous epithelium (VE) into M cells in wild-type mice 18 . 
Many transcription factors are involved in the cell-fate 'decisions' made as intestinal epithelial stem cells in the crypt differentiate into one of the recognized types of terminally differentiated intestinal epithelial cells. Math1 (Atoh1), which is repressed by the Notch effector Hes1, is essential for the commitment of epithelial progenitor cells into the secretory lineage, including goblet cells, Paneth cells, enteroendocrine cells and tuft cells 19, 20 . Downstream of Math1, the specification of the individual secretory cell lineages requires at least one additional transcription factor: KLF4 is required for the maturation of goblet cells 21 ; Sox9 is required for the maturation of Paneth cells 22, 23 ; and neurogenin 3 is required for the maturation of enteroendocrine cells 24 . By analogy, M-cell differentiation is hypothesized to require regulation by one (or more) distinct transcription factor(s), although its (or their) identity is yet to be determined.
In this study, we took advantage of the exogenous administration of recombinant RANKL as a means of synchronously inducing M-cell differentiation throughout the small intestinal epithelium 18 to identify genes induced during the process of M-cell differentiation. We found substantially more transcripts encoding the Ets family transcription factor Spi-B at an early stage of RANKL-induced M-cell differentiation and these were expressed specifically by naturally occurring M cells in the FAE of PPs. So far, Spi-B has been shown to be expressed only in hematopoietic cells, such as B cells and T cells 25 and plasmacytoid dendritic cells 26 ; therefore, our study provides the first evidence to our knowledge of Spi-B expression in nonhematopoietic cells. We further demonstrate that Spi-B is a regulatory factor for the differentiation of intestinal M cells.
RESULTS

Sequential induction of M-cell markers by RANKL
The systemic treatment of mice with RANKL has been identified as a means of inducing ectopic M-cell differentiation in the VE of the small intestine 18 . In addition to RANKL-induced M cells, a few intrinsic M cells, called 'villous M-like cells' , have also been identified in the VE 7, 27 . Unlike the authentic M cells in the PP FAE, villous M-like cells do not express the M-cell markers GP2 and Marcksl1 (ref. 7) .
To characterize the RANKL-induced M cells in detail, we first examined the kinetics of the expression of M-cell markers such as GP2, Marcksl1, CCL9, M-Sec, Sgne-1 and annexin V on these cells. The FAE has high CCL9 expression 10 ; here we confirmed the 'preferential' expression of CCL9 in M cells by dual staining for GP2 (Supplementary Fig. 1) . Genes encoding all of these markers were upregulated in the VE of distal ileum after treatment with glutathione S-transferase-RANKL (Fig. 1a and Supplementary  Fig. 2 ), which suggested that RANKL-induced ectopic M cells in the villi more closely resembled FAE M cells than the rare, naturally occurring villous M-like cells. Of note, the kinetics of expression of these M-cell markers after treatment with RANKL were distinct; the expression of Marcksl1, CCL9 and GP2 peaked after 1, 2 and 3 d, respectively, both as mRNA (Fig. 1a) and protein (Fig. 1b) . Furthermore, the localization of these M-cell markers moved from the crypt zones toward the tips of the villi from day 1 to day 3 after the treatment with RANKL, with Marcksl1 limited to the crypt-villus junction at day 1 and GP2 expression restricted to the upper part of villi on day 3 (Fig. 1b) 
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A r t i c l e s intestinal crypt-villus axis reflects their degree of maturation, these observations indicated that Marcksl1 expression began at an early stage of M-cell differentiation, whereas expression of CCL9 and GP2 required further maturation of the RANKL-induced M cells. As the induction of M-cell differentiation on small intestinal villi after the administration of exogenous RANKL is a nonphysiological pathway for intestinal M-cell induction, we investigated whether naturally developing PP M cells acquired these markers in the same order as noted during RANKL-induced differentiation. For this, we monitored the ontogenic expression of these M-cell markers in developing mouse PP FAE. It has been reported that the PP FAE structure is clearly distinguishable from embryonic day 18.5 (ref. 28) , with morphologically mature M cells being first identified between 5 d and 10 d postpartum 29 . Therefore, the first appearance of M cells should be detectable in this period (embryonic day 18.5 to postpartum day 10). We found that Marcksl1 was already expressed on a subset of cells in the FAE by embryonic day 18.5, whereas we first identified CCL9 on postpartum day 2 and did not detect individual GP2 + cells until postpartum day 7 ( Supplementary Fig. 3 ), which suggested that GP2 was expressed only on mature M cells. On the basis of these findings, we propose that the process of M-cell differentiation can be practically divided into a series of distinct stages defined by the expression profile of M-cell markers and that in vivo treatment with RANKL is a powerful experimental tool for tracing the individual steps of M-cell differentiation.
'Preferential' expression of Spi-B by intestinal M cells
The identification of M-cell lineage-specific transcription factors expressed early in M-cell differentiation is key in elucidating the molecular mechanisms of M-cell differentiation. Whole-genome expression profiling of mouse VE showed considerable upregulation of the gene encoding Spi-B shortly after treatment with RANKL ( Fig. 2a) . Real-time PCR analysis confirmed high expression of Spi-B mRNA in PP FAE but not in VE (Fig. 2b) . In situ hybridization (ISH) also demonstrated the distribution of Spi-B mRNA after treatment with RANKL. We observed Spi-B mRNA in the crypt as early as 6 h after treatment. By day 1 after treatment, Spi-B + cells were concentrated in the transit-amplifying cell compartment in the mid-crypt and migrated further up the crypt-villus axis at later time points (Fig. 2c) . In the PPs, Spi-B mRNA was expressed in a subset of FAE cells that also bound UEA-I, a lectin that recognizes M cells (Fig. 2d) .
We detected Spi-B protein in the nuclei of crypt cells at 18 h after treatment with RANKL and in the GP2 + M cells of PPs from untreated mice (Fig. 2e) . In addition, we observed Spi-B mRNA in a subset of cells in the PP FAE of mouse embryos at embryonic day 18.5 ( Fig. 2f) . The parallel upregulation of the gene encoding Spi-B during both natural M-cell development in the PP during ontogeny and after RANKL-induced M-cell differentiation in the VE suggested a pivotal role for Spi-B in the induction of intestinal M-cell differentiation. We also examined Spi-B expression in various GALTs in addition to PPs, such as isolated lymphoid follicles, colonic patches and cecal patches, and found that M cells in these tissues also expressed Spi-B mRNA (Fig. 2f) . To assess the possibility that human M cells also express Spi-B, we examined the expression of Spi-B in human PPs by ISH and found that Spi-B mRNA was 'preferentially' expressed in human M cells ( Supplementary Fig. 4 ).
To determine if Spi-B is required for normal M-cell differentiation, we examined Spi-B-deficient (Spib −/− ) mice. Whole-mount staining a b (Fig. 3a,b) . Real-time PCR analysis also showed a nearly complete loss of transcripts for GP2, CCL9, M-Sec and Sgne-1 in these mice ( Fig. 3c and Supplementary Fig. 5 ). We also observed loss of the expression of these M-cell markers in Spib −/− mice during RANKLinduced M-cell differentiation ( Fig. 4 and Supplementary Fig. 6 ).
In contrast, the expression of mRNA for Marcksl1 and annexin V in both natural PP M cells and RANKL-induced M cells from Spib −/− mice was maintained at an amount equivalent to that in cells from wild-type mice (Figs. 3c and 4b and Supplementary Figs. 5 and 6).
On the basis of these observations, we propose that the expression of GP2, CCL9, M-Sec and Sgne-1 in M cells is dependent on Spi-B, whereas the expression of Marcksl1 and annexin V is independent of Spi-B. Of note, we found cells expressing Marcksl1 (Fig. 3b) and annexin V (data not shown) near the apex of PP FAE from Spib −/− mice, which indicated that Spi-B was required for the expression of late markers of M-cell differentiation but was dispensable for the survival of the Marcksl1 + annexin V-positive cells, which allowed them to migrate toward the top of the FAE before their death.
Spi-B is critical for M-cell differentiation
In the PP FAE of Spib −/− mice, cells expressing only Marcksl1 and annexin V were present but lacked other M-cell markers that are normally acquired at later stages of differentiation. As GP2 is a functional antigen-uptake receptor on M cells 6 and is acquired at a late stage of M-cell differentiation, this molecule is considered a marker for terminally differentiated, fully functional M cells. We therefore hypothesized that the residual Marcksl1 + annexin V-positive cells in the PP FAE of Spib −/− mice were not functionally mature M cells. To explore that possibility, we examined transcytotic activity, a critical function of M cells that enables the rapid delivery of particulate luminal antigens across the epithelial barrier. We used oral administration of fluorescent nanoparticles, an established assay of M-cell transcytosis 30 , to Spib −/− and wild-type mice. In wild-type mice, particles were abundant in the subepithelial dome area of PPs, whereas very few particles were taken up into the PPs of Spib −/− mice (Fig. 5a,b) . We further investigated the loss of M-cell function in the PPs of Spib −/− mice by examining the translocation of orally administered bacteria. There was much less uptake of Salmonella enterica serovar Typhimurium (S. Typhimurium) in PPs of Spib −/− mice than in the PPs of wild-type mice. This result was consistent with the absence of GP2 + M cells in Spib −/− mice because the uptake of S. Typhimurium is considerably impaired in GP2-deficient mice 6 . In addition, PPs from Spib −/− mice had a significantly smaller bacterial load of Yersinia enterocolitica after oral administration of these bacteria (P = 0.0003; Supplementary Fig. 7) , which suggested that GP2-independent bacterial uptake was also impaired in the PPs of Spib −/− mice. Thus, the residual Marcksl1 + annexin V-positive cells in Spib −/− mice were defective in their ability to take up luminal antigens.
Consistent with the absence of transcytotic ability of the residual Scanning and transmission electron microscopy showed that the FAE of Spib −/− mice completely lacked cells with these morphological features (Fig. 5c,d ). In contrast, we observed no obvious defect in the development of goblet cells, Paneth cells or enteroendocrine cells in Spib −/− mice ( Supplementary Fig. 8 ), which indicated that Spi-B was not involved in the differentiation of these secretory intestinal epithelial cell lineages. On the basis of these observations, we propose that Spi-B has a crucial role in the differentiation of morphologically and functionally mature M cells and that its role in cellular differentiation is specific to M cells among the known types of intestinal epithelial cells.
M-cell differentiation requires intrinsic Spi-B
In the hematopoietic system, Spi-B is known to be involved in the function and development of B cells 31 . In addition, it has been reported that B cells contribute to M-cell differentiation [14] [15] [16] . On the basis of those studies, the possibility that absence of Spi-B in these cells of the immune system, but not in M cells themselves, was responsible for the observed defects in M-cell differentiation could not be excluded. (Fig. 7a) , which indicated that the transferred SM1 T cells migrated normally into PPs in the absence of Spi-B. SM1 T cells in the PPs of uninfected wild-type mice had the naive phenotype of low surface expression of the activation marker CD69, which increased considerably 24 h after oral infection with S. Typhimurium. In contrast, the induction of CD69 on SM1 T cells after infection was significantly impaired in Spib −/− mice (Fig. 7) .
The defect in T cell activation after oral antigen challenge was probably not a result of impaired antigen presentation due to the absence of Spi-B in hematopoietic cells, as we observed equivalent systemic activation of T cells directed against S. Typhimurium administered intraperitoneally in Spib −/− or wild-type mice given transfer of SM1 T cells (Supplementary Fig. 9 ). To further exclude the possibility of effects attributable to the absence of Spi-B in hematopoietic cells, we prepared bone marrow chimeras by transferring wild-type bone marrow into wild-type and Spib −/− recipients. After reconstitution, wild-type and Spib −/− bone marrow chimeras received SM1 T cells labeled with the cytosolic dye CFSE, and we subsequently infected them orally with S. Typhimurium. At 3 d after infection, we analyzed the proliferation of SM1 T cells in the bone marrow chimeras. At this time point, most SM1 T cells in wild-type recipients of wild-type marrow had undergone one (or more) division(s). In contrast, SM1 T cells in Spib −/− recipients of wild-type marrow showed a lower proliferative response (Supplementary Fig. 10 ). Together these results confirmed that the M cell-intrinsic expression of Spi-B was critical for the differentiation of M cells required for the host to initiate an efficient antigen-specific mucosal immune response.
DISCUSSION
Here we have reported that that Spi-B is a RANKL-induced transcription factor essential for the differentiation of intestinal M cells. The identification of Spi-B as a candidate 'master regulator' of M-cell differentiation resolves a longstanding question about the genesis of M cells and demonstrates a previously unknown and unanticipated function for Spi-B. Furthermore, the lack of M cells in Spi-B-deficient mice also provides a unique tool for elucidating the physiological and pathological functions of this enigmatic type of epithelial cell.
Spi-B is a member of the Ets family of transcription factors 34 . Spi-B is reported to have a role in signaling via the B cell antigen receptor, antibody responses and germinal-center formation 35 , as well as B cell development 31, 36 . In addition, Spi-B is required for development of human plasmacytoid dendritic cells 37 . In this study, we found high expression of Spi-B in both RANKL-induced M cells and PP FAE M cells. This 'preferential' expression of Spi-B in intestinal M cells is the first demonstration, to our knowledge, of Spi-B expression in nonhematopoietic cells. Furthermore, we found that Spib −/− mice completely lacked M cells in PPs, which provides evidence that M-cell differentiation is regulated by a specific transcription factor, as has been shown for most other intestinal epithelial cell lineages. In addition, Spi-B expression in M cells was conserved in all mouse GALT, as well as M cells in human PPs, which suggests an essential role for Spi-B in M-cell differentiation.
Many transcription factors of the Ets family other than Spi-B are expressed in epithelial cells of the small intestine. However, identifying the function of individual Ets transcription factors in these cells has been challenging, in part because of the potential for compensatory activity by other Ets factors coexpressed in the absence of a single Ets transcription factor 38 . Although nearly two-thirds of all Ets transcription factors have been inactivated genetically in mice, the absence of just two of these factors due to genetic inactivation has been reported to perturb intestinal epithelial cell differentiation. Mice with homozygous deficiency in the transcription factor Elf3 show abnormal morphogenesis of villi and terminal differentiation of enterocytes and goblet cells 39 . In contrast, homozygous deletion of the gene encoding the transcription factor Spdef impairs the full maturation of both goblet cells and Paneth cells 40 . The indispensable role of Spi-B in M-cell differentiation indicates that all other Ets transcription factors expressed in M cells are unable to replace Spi-B in orchestrating M-cell differentiation.
The relationship between the expression pattern of M-cell markers and the lack of M cells in Spib −/− mice has greatly improved the understanding of M-cell differentiation. The FAE in Spib −/− mice lacked several M cell-associated markers, including GP2, CCL9, M-Sec and Sgne-1, which indicated that induction of the genes encoding these in M cells required Spi-B expression. GP2 is thought to be a marker of terminally differentiated, functional M cells because of its role in the uptake of pathogenic and commensal bacteria 6 . In contrast to the dependence on Spi-B for the expression of most M cell-associated markers and full functional maturation of M cells, we found that the expression of Marcksl1 and annexin V was not lower in Spib −/− cells from either the PP FAE or the VE after treatment with RANKL. These Marcksl1 + annexin V-positive cells in Spib −/− mice lacked not only GP2 expression but also the ability to take up macromolecules, as well as typical M-cell morphologies such as irregular microvilli and a pocket-like basolateral invagination. These observations suggested that Spi-B is essential for the morphological and 41 . Its expression preceded GP2 expression during both RANKLinduced and FAE M-cell differentiation. In addition, we found that Spi-B directly bound the promoter region of the gene encoding CCL9 in vitro (data not shown), which raised the possibility of a substantial role for CCL9 in M-cell maturation. CD11b + dendritic cells attracted to the subepithelial dome by CCL9 may provide signals that contribute to the terminal differentiation of M cells. M-Sec was also dependent on Spi-B expression during the RANKL-induced differentiation of M cells. M-Sec has been shown to be involved in the formation of tunneling nanotubes 11 , which indicates that the appearance of the tunneling nanotube structures observed in M cells is also a feature of fully mature M cells. Marcksl1 was one of the earliest M-cell markers found to be expressed in response to treatment with RANKL; it was expressed mainly at the crypt-villus junction but not by fully differentiated villous enterocytes shortly after such treatment. This suggests that the cells in the crypt, most probably undifferentiated transit-amplifying cells, can respond to the activation of RANKL signaling through RANK with the induction of Marcksl1. Notably, the frequency of Marcksl1 + annexin V-positive cells in the epithelium decreased at later time points after the onset of treatment with RANKL, and the remaining Marcksl1 + annexin V-positive cells began to coexpress M-cell markers that appear later, such as CCL9 and GP2. Given that Spi-B is essential for the expression of CCL9, GP2, M-Sec and Sgne-1 in M cells, we hypothesize that only the cells that achieve successful induction of Spi-B by RANKL fully commit to M-cell differentiation, which allows them to maintain expression of Marcksl1 and annexin V, progress through M-cell differentiation and express markers of later stages characteristic of mature M cells. In contrast, those cells that fail to express Spi-B do not sustain the expression of Marcksl1 and annexin V and instead eventually commit to differentiation into other types of mature enterocytes. Lateral inhibition by committed M cells may be one mechanism that contributes to the suppression of the expression of Marcksl1 and annexin V by the surrounding cells, as observed in cells of the secretory lineage 42 . That is in agreement with the observation that in Spib −/− mice, residual Marcksl1 + annexin Vpositive cells reached the apex of the FAE, as well as the villus tips, after treatment with RANKL. The Spi-B-independent expression of Marcksl1 and annexin V in the initial phase of RANKL-induced M-cell differentiation probably indicates that these proteins may be markers of RANKL-responsive intestinal epithelial cells.
In summary, our study has demonstrated that Spi-B is an essential transcription factor that regulates M-cell differentiation. Our investigation of M-cell differentiation in Spib −/− mice showed tight linkage between the acquisition of Spi-B-dependent expression of M-cell markers and the induction of fully functional M cells. In addition, we observed much less activation of antigen-specific T cells in Spib −/− mice, which confirmed the importance of M cells in the induction of adaptive immune responses in the intestinal GALT. Spi-B-deficient mice serve as a unique tool for elucidating the physiological and pathological functions of M cells.
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